Baudax Bio Financials

BXRXDelisted Stock  USD 0.76  0.06  7.32%   
Based on the analysis of Baudax Bio's profitability, liquidity, and operating efficiency, Baudax Bio is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.
  
Understanding current and past Baudax Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Baudax Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Baudax Bio's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Baudax Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Baudax Bio. Check Baudax Bio's Beneish M Score to see the likelihood of Baudax Bio's management manipulating its earnings.

Baudax Bio Stock Summary

Baudax Bio competes with Virax Biolabs, Altamira Therapeutics, Palisade Bio, Allarity Therapeutics, and Cns Pharmaceuticals. Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. Baudax Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 80 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS07160F2065
Business Address490 Lapp Road,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.baudaxbio.com
Phone484 395 2440
CurrencyUSD - US Dollar

Baudax Bio Key Financial Ratios

Baudax Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Baudax Bio's current stock value. Our valuation model uses many indicators to compare Baudax Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Baudax Bio competition to find correlations between indicators driving Baudax Bio's intrinsic value. More Info.
Baudax Bio is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Baudax Bio's earnings, one of the primary drivers of an investment's value.

Baudax Bio Market Pulse

 Quote0.76
 Change(%)  7.32 
 Change0.06 
 Open0.82
 Low0.75
 High0.87
 Volume0
 ExchangeNASDAQ

Steps to analyze company Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Baudax Bio is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Baudax has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Baudax Bio's financials are consistent with your investment objective using the following steps:
  • Review Baudax Bio's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Baudax Bio's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Baudax Bio's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Baudax Bio's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Baudax Bio November 24, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Baudax Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Baudax Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Baudax Bio based on widely used predictive technical indicators. In general, we focus on analyzing Baudax Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Baudax Bio's daily price indicators and compare them against related drivers.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Baudax Stock

If you are still planning to invest in Baudax Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baudax Bio's history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk